Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard James

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Inorganic Biochemistry|September 10, 2021
Pd(II) complexes with chelating N-(1-alkylpyridin-4(1H)-ylidene)amide (PYA) ligands: Synthesis, characterization and evaluation of anticancer activityMuhammad Naveed Zafar, Abdul Mannan Butt, Gul-E-Saba Chaudhry, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancerPaul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Chinese Medical Journal|May 10, 2021
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 studyYuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Inorganic Biochemistry|September 10, 2021
Pd(II) complexes with chelating N-(1-alkylpyridin-4(1H)-ylidene)amide (PYA) ligands: Synthesis, characterization and evaluation of anticancer activityMuhammad Naveed Zafar, Abdul Mannan Butt, Gul-E-Saba Chaudhry, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancerPaul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Chinese Medical Journal|May 10, 2021
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 studyYuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, et al.
Pageof 2